Cargando…

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy

Resistance to systemic therapy is a major problem in metastatic breast cancer (MBC) that can be explained by initial tumor heterogeneity as well as by evolutionary changes during therapy and tumor progression. Circulating tumor cells (CTCs) detected in a liquid biopsy can be sampled and characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aaltonen, Kristina E., Novosadová, Vendula, Bendahl, Pär-Ola, Graffman, Cecilia, Larsson, Anna-Maria, Rydén, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542207/ https://www.ncbi.nlm.nih.gov/pubmed/28489591 http://dx.doi.org/10.18632/oncotarget.17271

Ejemplares similares

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
por: Larsson, Anna-Maria, et al.
Publicado: (2018)

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
por: Jansson, Sara, et al.
Publicado: (2016)

The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance
por: Narbe, Ulrik, et al.
Publicado: (2020)

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells
por: Forsare, Carina, et al.
Publicado: (2020)

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
por: Larsson, Anna-Maria, et al.
Publicado: (2020)

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2021)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
por: Jansson, Sara, et al.
Publicado: (2014)

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2020)

Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
por: Gunnarsdottir, Frida Björk, et al.
Publicado: (2023)

The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology
por: Dihge, Looket, et al.
Publicado: (2016)

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation
por: Frithiof, Henrik, et al.
Publicado: (2015)

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
por: Alkner, Sara, et al.
Publicado: (2016)

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
por: Falck, Anna-Karin, et al.
Publicado: (2013)

Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
por: Hagman, Helga, et al.
Publicado: (2018)

Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study
por: Mohlin, Åsa, et al.
Publicado: (2021)

Prediction of outcome after diagnosis of metachronous contralateral breast cancer
por: Alkner, Sara, et al.
Publicado: (2011)

Artificial neural network models to predict nodal status in clinically node-negative breast cancer
por: Dihge, Looket, et al.
Publicado: (2019)

A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
por: Frithiof, Henrik, et al.
Publicado: (2016)

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor
por: Narbe, Ulrik, et al.
Publicado: (2014)

The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
por: Dihge, Looket, et al.
Publicado: (2023)

Co-localization of CD169(+) macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
por: Björk Gunnarsdottir, Frida, et al.
Publicado: (2020)

Psychological Resilience and Health-Related Quality of Life in Swedish Women with Newly Diagnosed Breast Cancer
por: Mohlin, Åsa, et al.
Publicado: (2020)

Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
por: Bendahl, Pär-Ola, et al.
Publicado: (2023)

The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
por: Skarping, Ida, et al.
Publicado: (2022)

Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development
por: Hjärtström, Malin, et al.
Publicado: (2023)

One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
por: Veličković, Katarina, et al.
Publicado: (2022)

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
por: Olsson, Eleonor, et al.
Publicado: (2015)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
por: Tutzauer, Julia, et al.
Publicado: (2020)

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
por: Falck, Anna-Karin, et al.
Publicado: (2012)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
por: Lundgren, Christine, et al.
Publicado: (2020)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
por: Skarping, Ida, et al.
Publicado: (2022)

No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression
por: Förnvik, Daniel, et al.
Publicado: (2013)

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
por: Lundgren, Christine, et al.
Publicado: (2022)

Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
por: Lundgren, Christine, et al.
Publicado: (2023)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
por: Forsare, Carina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2cha2up2jbr4q9q5jbv57bi8fh